Convalescent plasma for patients with COVID-19
- PMID: 32398379
 - PMCID: PMC7293648
 - DOI: 10.1073/pnas.2006961117
 
Convalescent plasma for patients with COVID-19
Conflict of interest statement
The authors declare no competing interest.
Comment in
- 
  
  Reply to Kesici et al. and Zeng et al.: Blocking the virus and reducing the inflammatory damage in COVID-19.Proc Natl Acad Sci U S A. 2020 Jun 9;117(23):12529-12530. doi: 10.1073/pnas.2007408117. Epub 2020 May 12. Proc Natl Acad Sci U S A. 2020. PMID: 32398377 Free PMC article. No abstract available.
 
Comment on
- 
  
  Effectiveness of convalescent plasma therapy in severe COVID-19 patients.Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496. doi: 10.1073/pnas.2004168117. Epub 2020 Apr 6. Proc Natl Acad Sci U S A. 2020. PMID: 32253318 Free PMC article.
 
References
- 
    
- WHO , WHO virtual press conference on COVID-19. https://www.who.int/docs/default-source/coronaviruse/transcripts/who-aud.... Accessed 16 March 2020.
 
 - 
    
- Lozano M., Cid J., Müller T. H., Plasma treated with methylene blue and light: Clinical efficacy and safety profile. Transfus. Med. Rev. 27, 235–240 (2013). - PubMed
 
 
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
